California Seeks to Stop Pay-to-delay Generic Drug Agreements

Three of the top pharmaceutical companies have entered agreements to pay the state of California nearly $70 million to settle allegations that they “delayed drugs to keep prices high” according to California Attorney General Xavier Becerra.  Most of the funds will come from Teva Pharmaceuticals ($69 million) for paying to delay a generic for Provigil,